Discontinuation report TEVA-ATENOLOL

Last updated on 2020-02-13 History
Report ID 106142
Drug Identification Number 02171791
Brand name TEVA-ATENOLOL
Common or Proper name ATENOLOL
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ATENOLOL
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30's
ATC code C07AB
ATC description BETA BLOCKING AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-12-28
Remaining supply date 2017-12-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-02-13 English Compare
v2 2020-02-13 French Compare